Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Szu S. Wong"'
Autor:
Szu S. Wong
Publikováno v:
IUPHAR/BPS Guide to Pharmacology CITE. 2023
Coagulation as a process is interpreted as a mechanism for reducing excessive blood loss through the generation of a gel-like clot local to the site of injury. The process involves the activation, adhesion (see Integrins), degranulation and aggregati
Autor:
Huw E. L. Williams, Caroline Armstrong, Simon G. Caulton, José A. López, Szu S. Wong, Juliet Morgan, Ruiqi Ng, Muhammad Saleem, Jonas Emsley, Alice Fickling, Mark S. Searle, Adam D. Munday
Publikováno v:
'Blood Advances ', vol: 3, pages: 1450-1459 (2019)
Cell-surface receptor interactions between leukocyte integrin macrophage-1 antigen (Mac-1, also known as CR3, αMβ2, CD11b/CD18) and platelet glycoprotein Ibα (GPIbα) are critical to vascular inflammation. To define the key residues at the binding
Autor:
Szu S. Wong
Publikováno v:
IUPHAR/BPS Guide to Pharmacology CITE. 2021
Coagulation as a process is interpreted as a mechanism for reducing excessive blood loss through the generation of a gel-like clot local to the site of injury. The process involves the activation, adhesion (see Integrins), degranulation and aggregati
Autor:
Szu S. Wong, Henning R. Stennicke, Jonas Emsley, Gareth Hall, Chan Li, Søren Østergaard, Philip M. Williams
Factor XI (FXI) is the zymogen of FXIa, which cleaves FIX in the intrinsic pathway of coagulation. FXI is known to exist as a dimer and interacts with multiple proteins via its 4 apple domains in the “saucer section” of the enzyme; however, to da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4c7cd9c70720301f705c258409c8f6a0
https://europepmc.org/articles/PMC4991086/
https://europepmc.org/articles/PMC4991086/